Brainsway Stock

Brainsway Debt 2025

Brainsway Debt

-10.05 USD

Ticker

BWAY.TA

ISIN

IL0011007189

WKN

A0NDVW

In 2025, Brainsway's total debt was -10.05 USD, a -78.66% change from the -47.09 USD total debt recorded in the previous year.

Brainsway Aktienanalyse

What does Brainsway do?

Brainsway Ltd is a leading provider of non-invasive brain stimulation solutions based in Jerusalem, Israel. The company was founded in 2003 and has since become a major player in the field of neurological disorders. Brainsway's business model includes the development, production, and marketing of innovative brain stimulation solutions. The company's products are based on transcranial magnetic stimulation (TMS), a proven technology for treating neurological disorders. TMS involves generating brain stimulation through a non-invasive method, using gentle magnetic pulses directed at the targeted area of the brain to specifically influence brain activity. The company is divided into three business areas: psychiatry, neurology, and rehabilitation. The psychiatry area includes the treatment of disorders such as depression, obsessive-compulsive disorder, addiction, and schizophrenia. The neurology area, on the other hand, focuses on disorders such as Parkinson's disease, Alzheimer's disease, and epilepsy. The rehabilitation area is used for anatomical rehabilitation and stroke rehabilitation and is the newest product of Brainsway. Each area includes a variety of products tailored to the individual needs of users. One of Brainsway's most well-known products is the Deep TMS Stimulator, which was specifically developed for the treatment of depression. The Deep TMS therapy has been clinically tested and identified as an effective method for treating depression, obsessive-compulsive disorder, and ADHD. The device has already been marketed in over twenty countries. Brainsway is also a leader in the treatment of Parkinson's disease with TMS. Clinical studies have shown that the application of Brainsway TMS in Parkinson's patients reduces symptoms by almost 50%. The benefits of TMS in Parkinson's include improved motor function, increased quality of life, and a reduction in the frequency of falls. The company has established collaborations with major pharmaceutical companies and research institutions. Brainsway works closely with scientific institutions to continuously develop and improve therapies and products. Brainsway Ltd is an innovative company that is a leader in the field of non-invasive brain stimulation. Brainsway's products have proven to be effective in treating a variety of disorders, and the company has a promising future in researching and developing new therapies. Brainsway ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Brainsway's Debt Structure

Brainsway's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Brainsway's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Brainsway’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Brainsway’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Brainsway stock

What is the debt of Brainsway this year?

Brainsway has a debt level of -10.05 USD this year.

What was the debt of Brainsway compared to the previous year?

The debt of Brainsway has increased by -78.66% compared to the previous year dropped.

What are the consequences of high debt for investors in Brainsway?

High debt can pose a risk for investors of Brainsway, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Brainsway?

Low debt means that Brainsway has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Brainsway affect the company?

An increase in debt of Brainsway can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Brainsway affect the company?

A reduction in debt of Brainsway can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Brainsway?

Some factors that can influence the debt of Brainsway include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Brainsway so important for investors?

The debts of Brainsway are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Brainsway take to change the debt?

To change the debt, Brainsway can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Brainsway pay?

Over the past 12 months, Brainsway paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Brainsway is expected to pay a dividend of 0 USD.

What is the dividend yield of Brainsway?

The current dividend yield of Brainsway is .

When does Brainsway pay dividends?

Brainsway pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Brainsway?

Brainsway paid dividends every year for the past 0 years.

What is the dividend of Brainsway?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Brainsway located?

Brainsway is assigned to the 'Health' sector.

Wann musste ich die Aktien von Brainsway kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Brainsway from 3/7/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/7/2025.

When did Brainsway pay the last dividend?

The last dividend was paid out on 3/7/2025.

What was the dividend of Brainsway in the year 2024?

In the year 2024, Brainsway distributed 0 USD as dividends.

In which currency does Brainsway pay out the dividend?

The dividends of Brainsway are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Brainsway

Our stock analysis for Brainsway Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Brainsway Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.